Standard protocol in the Philippines is one 700mg dose followed by three 350mg doses. Which would be $2.5k and 120 patients. The problem in the Philippines is that the cost of the drug must be paid upfront and that cost is beyond the means of even most middle class Filipinos. I suspect most hospitals who are approved for leronlimab use will keep just enough on hand to treat their wealthy clients.